Chairpersons: I. Boukovinas, A. Kyriazoglou
Tissue microenvironment and immunotherapy in sarcomas P. Foukas
Chairpersons: I. Boukovinas, A. Kyriazoglou
Introducing the combination of Nivolumab-sunitinib in the therapeutic varmamentarium of soft tissue and bone sarcomas J-M. Broto
Chairpersons: I. Boukovinas, A. Kyriazoglou
Immunotherapy for patients with sarcoma: pathological or biological driven choice A. Dufresne
Discussion - Conclusions